None listed
Conditions
Brief summary
Study design: This is a pilot single-blinded randomised sham-controlled clinical trial with three-armed group design. Participants: Eligible participants must fulfil the inclusion criteria a) Being overweight (BMI greater or equal to 25) or obese with BMI between 30 and less 40; b) Adult with age over 18 years old; c) Be available during the period of this clinical trial; d) Agree to provide written consent for participating this clinical trial. The exclusion criteria: a) Serious chronic medical conditions, such as cardiovascular diseases, cancer, HIV; b) Pregnancy or lactation; c) Drug induced secondary obesity; d) Medical conditions which are known to link with obesity, such as polycystic ovary syndrome, hypothyroidism, Cushing syndrome, Hashimoto’s Disease; e) Mental conditions such as clinical depression and anxiety; f) Participants who are not willing to be treated by acupuncture or to practise meditation; g) Difficulties in understanding and reading English; h) Taking blood thinning medications; i) Auditory disorders who cannot listen to audio records; j) Participants who received treatment for overweight in the past 3 months, including medical treatment or participation in weight loss programs. Sample size was calculated based on the study by Gugel et al. (2012) comparing the acupuncture group with the sham acupuncture on BMI after treatment, the effect size estimate was 0.56. The sample size pilot trial will be 10 participants per group. The recruited participants will be randomised in to 3 groups: Electroacupuncture plus Mindfulness Meditation (EAM), Sham Electroacupuncture plus Mindfulness Meditation (SAM) and Electroacupuncture only (EAO). Treatment protocol: After two-week run-in period, all randomised participants will receive 1 session per week for 12 weeks and 8 weeks follow-up. During each session, the EAM group will receive 30-minute real EA using 8 weight-loss specific points and 10-minute MM practice with instructions for daily practice. SAM group will receive 30 minute SAM with 8 sham acupuncture points (1cm away from real acupuncture points and meridian) and10-minute MM practice. The EAO group will receive only real EA without MM. Data collections: The data will be collected at week 0, 3, 6, 9, 12, 14, 16, 20 weeks using validated and licensed instruments (obtained). Outcome measures include weight, BMI, waist and hips ratio, weight-related symptom measure (WRSM) and obesity and weight loss quality of life (OWL-QOL), Food intake and Power of food scale. The ethics application has been submitted to RMIT-HREC for approval. Statistical analysis: All collected data will be analysed comparing between groups and within group using SPSS. Intention-to-treat analysis will be applied to all clinical data collected.
Interventions
All randomised participants will have one treatment session per week for a period of 12 weeks and a 8 week follow up period. Electroacupuncture (EA) The intervention consists of 12 weekly sessions, each session includes EA treatment with 30 mins needles retention EA point selection includes Zusanli (ST36), Sanyinjiao (SP6), Tianshu (ST25), Zhongwan (CV12), Fenglong (ST40), Guanyuan (CV4), Qihai (CV6), Yinlingquan (SP9). The location of the acupuncture points will follow the standard point location in western Pacific region published by WHO (World Health Organization, 2008). Stainless steel single-use disposable needles (Seirin, Seirin Coporation, Japan) will be used and the needles are sterilised, individually packed with a length of 40 mm. Skin sterilisation will be performed by applying 70% isopropyl alcohol swab to the area. All acupuncture points will be needled perpendicularly with guide tube. Insertion depth will be approximately 25 mm, depending on the location of individual points. Each point will be connected to an electro-stimulator continuous wave at a frequency of 30 Hz. All needles will be removed after 30 minutes of electro-stimulation. A registered acupuncturist will be responsible for administering the EA treatments; they will also be responsible for recording each treatment into the participant’s treatment logbook. The details of the logbook include date, time, the duration of the treatment, practice of mindfulness meditation, adverse event and signed by the acupuncturist. Mindfulness Meditation The mindfulness meditation (MM) intervention involved practising a 10-minutes pre-recorded mindfulness meditation after each acupuncture treatment. They will also be instructed to self-practise mindfulness meditation daily at their own time, and be given a logbook to record the frequency and duration of their self-practised mindfulness meditation. This MM is adapted from the MB-EAT program which developed by Jean Kristeller (Kristeller & Hallett, 1999). It is a sitting meditation to be practised in individual settings, which requires participants to focus on their awareness through breathing, and the audio will be recorded by a registered psychologist. A copy of the mindfulness meditation information and instruction booklet will be given to the participants in the first treatment session. The booklet will explain what mindfulness meditation is, and provides clear instruction for practising mindfulness meditation.
Sponsors
Study design
Eligibility
Inclusion criteria
Being overweight (BMI greater or equal to 25) Adult, with age between 18 and 60. Be available during the period of this clinical trial
Exclusion criteria
- Serious chronic medical conditions, such as cardiovascular diseases, cancer, HIV, epilepsy - Pregnancy or lactation. - Drug induced secondary obesity - Medical conditions which are known to link with obesity, such as uncontrolled high blood pressure, polycystic ovary syndrome, hypothyroidism, Cushing syndrome, Hashimoto’s Disease - Mental conditions such as clinical depression, anxiety, PTSD, psychosis - Participants who are not willing to be treated by acupuncture or to practice meditation. - Difficulties with understanding and reading English - Taking blood thinning medications - Auditory impairment who cannot listen to audio records - Participants who received treatment for obesity in the past 3 months, including medical treatment or participated in weight loss programs.